Javascript must be enabled to continue!
Placental programming mediates the vicious cycle between maternal gestational diabetes and offspring type 2 diabetes in a novel mouse model
View through CrossRef
Accumulating evidence from human epidemiological studies indicates that there is a vicious cycle between maternal gestational diabetes (GDM) and offspring type 2 diabetes (T2D). However, the underlying mechanisms remain unclear. A handful of studies found that mitochondrial defects occur in the GDM placenta, including excess accumulation of destroyed mitochondria, reduced ATP and enhanced ROS production, which indicates that mitophagy, a specific process to remove destroyed mitochondria, may be impaired in the GDM placenta. Our recent study suggested that BNIP3 plays a critical role in maintaining mitochondria homeostasis in human trophoblast cells. Therefore, in this study, we hypothesized that conditional knockout of BNIP3 specifically in mouse trophoblast cells will recapitulate the typical symptoms of GDM in maternal pregnancy and T2D in offspring. First, we made male mice with double homozygous Cre and LoxP by breeding Cyp19-Cre and Bnip3-LoxP mice, which was used to mate females with homozygous LoxP, forming a cKO group. On the other hand, wild-type female mice were bred by males with homozygous Cre, forming a control group (CT). Second, offspring from cKO and CT mothers were allowed to grow up. On Day 18 of pregnancy, glucose tolerance test was conducted in pregnant cKO or CT mice. The placental tissues were collected and mRNA and protein levels of BNIP3 were measured by qPCR and Western blotting, respectively. In male offspring at the age of eight months, glucose tolerance test was conducted, and metabolic rate was measured by CaloBox Indirect Calorimetry. All numerical parameters between the cKO and CT pregnant mice, and between their male offspring were analyzed by ANOVA (n=5). The main findings include: 1) On Day 18 of pregnancy, BNIP3 mRNA and protein levels in the placental tissue were reduced by 47% and by 40% in cKO compared to CT mice (p<0.05), respectively (p<0.05); 2) Pregnant cKO mice demonstrated enhanced glucose intolerance compared to those control mice; 3) At the age of 8 months, the body weight of male offspring from cKO mothers was increased by 1.16-fold (p<0.05) compared to those from CT mothers; 4) Male offspring from cKO mothers demonstrated enhanced glucose intolerance compared to those from CT mothers; 5) The metabolic rates was lower in male offspring from cKO mothers compared to those from CT mothers, with decreased oxygen consumption and carbon dioxide production by 1.18- and 1.19-fold, respectively (p<0.05). These results suggest that placental programming possibly via the disrupted functions of BNIP3 in trophoblast cells mediates the occurrence of maternal GDM and offspring T2D, therefore, placental BNIP3 may play a critical role in the vicious cycle of maternal GDM and offspring T2D and thus, being a potential target in treatment of GDM and prevention of T2D. NIH research grants R03HD095417, U54MD007597. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
American Physiological Society
Title: Placental programming mediates the vicious cycle between maternal gestational diabetes and offspring type 2 diabetes in a novel mouse model
Description:
Accumulating evidence from human epidemiological studies indicates that there is a vicious cycle between maternal gestational diabetes (GDM) and offspring type 2 diabetes (T2D).
However, the underlying mechanisms remain unclear.
A handful of studies found that mitochondrial defects occur in the GDM placenta, including excess accumulation of destroyed mitochondria, reduced ATP and enhanced ROS production, which indicates that mitophagy, a specific process to remove destroyed mitochondria, may be impaired in the GDM placenta.
Our recent study suggested that BNIP3 plays a critical role in maintaining mitochondria homeostasis in human trophoblast cells.
Therefore, in this study, we hypothesized that conditional knockout of BNIP3 specifically in mouse trophoblast cells will recapitulate the typical symptoms of GDM in maternal pregnancy and T2D in offspring.
First, we made male mice with double homozygous Cre and LoxP by breeding Cyp19-Cre and Bnip3-LoxP mice, which was used to mate females with homozygous LoxP, forming a cKO group.
On the other hand, wild-type female mice were bred by males with homozygous Cre, forming a control group (CT).
Second, offspring from cKO and CT mothers were allowed to grow up.
On Day 18 of pregnancy, glucose tolerance test was conducted in pregnant cKO or CT mice.
The placental tissues were collected and mRNA and protein levels of BNIP3 were measured by qPCR and Western blotting, respectively.
In male offspring at the age of eight months, glucose tolerance test was conducted, and metabolic rate was measured by CaloBox Indirect Calorimetry.
All numerical parameters between the cKO and CT pregnant mice, and between their male offspring were analyzed by ANOVA (n=5).
The main findings include: 1) On Day 18 of pregnancy, BNIP3 mRNA and protein levels in the placental tissue were reduced by 47% and by 40% in cKO compared to CT mice (p<0.
05), respectively (p<0.
05); 2) Pregnant cKO mice demonstrated enhanced glucose intolerance compared to those control mice; 3) At the age of 8 months, the body weight of male offspring from cKO mothers was increased by 1.
16-fold (p<0.
05) compared to those from CT mothers; 4) Male offspring from cKO mothers demonstrated enhanced glucose intolerance compared to those from CT mothers; 5) The metabolic rates was lower in male offspring from cKO mothers compared to those from CT mothers, with decreased oxygen consumption and carbon dioxide production by 1.
18- and 1.
19-fold, respectively (p<0.
05).
These results suggest that placental programming possibly via the disrupted functions of BNIP3 in trophoblast cells mediates the occurrence of maternal GDM and offspring T2D, therefore, placental BNIP3 may play a critical role in the vicious cycle of maternal GDM and offspring T2D and thus, being a potential target in treatment of GDM and prevention of T2D.
NIH research grants R03HD095417, U54MD007597.
This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format.
There are no additional versions or additional content available for this abstract.
Physiology was not involved in the peer review process.
Related Results
Abstract P2075: The Effects Of Maternal Psychosocial Stress During Pregnancy On Offspring Heart Health
Abstract P2075: The Effects Of Maternal Psychosocial Stress During Pregnancy On Offspring Heart Health
Maternal health has a substantial effect on offspring well-being and health. A significant contributing factor to maternal health is psychosocial stress. Psychosocial stress result...
Maternal immune mechanisms and offspring neurodevelopment
Maternal immune mechanisms and offspring neurodevelopment
Inflammation during pregnancy occurs in gestational diabetes, preeclampsia, maternal stress, and other conditions. Convergent evidence from the human literature has associated gest...
Maternal underweight and obesity are associated with placental pathologies in human pregnancy
Maternal underweight and obesity are associated with placental pathologies in human pregnancy
AbstractIntroductionMaternal underweight and obesity are prevalent conditions, associated with chronic, low-grade inflammation, poor fetal development, and long-term adverse outcom...
ULTRASONOGRAPHIC CORRELATION OF PLACENTAL THICKNESS WITH GESTATIONAL AGE
ULTRASONOGRAPHIC CORRELATION OF PLACENTAL THICKNESS WITH GESTATIONAL AGE
Background: The placenta is a vital organ in pregnancy, and its sonographic thickness has emerged as
a supplementary parameter for assessing gestational age (GA) and fetal well-bei...
Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During Pregnancy
Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During Pregnancy
ImportanceLimited information exists regarding the impact of pharmacotherapy in pregnancy due to ethical concerns of unintended fetal harm. Yet, maternal prescriptive drug use for ...
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
ABSTRACT
Aims/hypothesis
Genetic prediction of type 2 diabetes risk has proven difficult using current methods. Recent studies have shown...
Gestational Glucose Intolerance and Risk of Future Diabetes
Gestational Glucose Intolerance and Risk of Future Diabetes
<p> </p>
<p><strong>Objective:</strong> Pregnant individuals are universally screened for gestational diabetes. Gestational glucose intolerance (GGI,...
Gestational Glucose Intolerance and Risk of Future Diabetes
Gestational Glucose Intolerance and Risk of Future Diabetes
<p> </p>
<p><strong>Objective:</strong> Pregnant individuals are universally screened for gestational diabetes. Gestational glucose intolerance (GGI,...


